
Feb 23 (Reuters) - MacroGenics Inc MGNX.O:
MACROGENICS ANNOUNCES PAUSING OF ENROLLMENT OF NEW STUDY PARTICIPANTS IN LINNET TRIAL
MACROGENICS INC: U. S. FOOD AND DRUG ADMINISTRATION (FDA) HAS PLACED A PARTIAL CLINICAL HOLD ON ITS PHASE 2 LINNET STUDY OF LORIGERLIMAB
MACROGENICS INC: CURRENT STUDY PARTICIPANTS MAY CONTINUE TO RECEIVE STUDY DRUG
MACROGENICS: FDA'S PARTIAL CLINICAL HOLD INITIATED AFTER CO'S NOTIFICATION TO FDA OF TEMPORARY PAUSE IN ENROLLMENT OF NEW PARTICIPANTS IN LINNET TRIAL
MACROGENICS: TEMPORARY PAUSE IN ENROLLMENT OF NEW PARTICIPANTS IN LINNET TRIAL DUE TO OCCURRENCE OF RECENT SAFETY EVENTS